Abtrait
Les hypogonadismes hypogonadotrophiques congénitaux sont une cause ďinsuffisance de développement pubertaire et ďinfertilité chez la femme et chez ľhomme (1). Ils résultent de la sécrétion insuffisante de gonadotrophines hypophysaires, LH et/ou FSH. Le traitement de ľinfertilité chez les hommes et les femmes est une demande habituelle des patients avec HHC après le traitement de ľhypogonadisme. Il pose actuellement, dans certaines étiologies, le problème de la transmission de la maladie à la descendance et génère une activité croissante de conseil génétique, de surveillance des grossesses induites médicalement et de prise en charge diagnostique et thérapeutique du nouveau-né.
Preview
Unable to display preview. Download preview PDF.
Références
Young J (2005) Hypogonadismes hypogonadotrophiques congénitaux: développement récents. In: Mises au point cliniques ďendocrinologie, nutrition et métabolisme. Éditions de Médecine Pratique, Franconville, 169–87
Liu L, Banks SM, Barnes KM, Sherins RJ (1988) Two-year comparison of testicular response to pulsatile gonadotropin-releasing hormone and exogeneous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocr Metab 67: 1140–5
Schaison G, Young J, Pholséna M et al. (1993) Failure of combined follicle-stimulating hormone-testosterone administration to iniciate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J Clin Endocr Metab 77: 1545–9
Burris AS, Rodbard HW, Winters SJ, Sherins RJ (1988) Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocr Metab 66: 1144–51
Finkel DM, Philipps JL, Snyder PJ (1985) Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 313: 651–5
Burris AS, Clark RV, Vantman DJ, Sherins RJ (1988) A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotrophin therapy. Fertil Steril 50: 343–8
Kirk JMW, Savage MO, Grant DB et al. (1994) Gonadal function and response to human chrionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism. Clin Endocrinol 41: 57–63
Burgues S, Calderon MD (1997) Spanish collaborative group on male hypogonadotropic hypogonadism. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotropin for the treatment of male hypogonadotropic hypogonadism. Hum reprod 5: 980–6
Gompel A, Mauvais-Jarvis P (1988) Induction of ovulation with pulsatile GnRH in hypothalamic amenorrhoea. Hum Reprod 3: 473–7
Martin KA, Hall JE, Adams JM, Crowley W (1993) Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocr Metab 77: 125–9
Couzinet B, Lestrat N, Brailly S et al. (1988) Stimulation of ovarian follicular maturation with pure FSH in women with gonadotropin deficiency. J Clin Endocr Metab 66: 552–6
Kousta E, White DM, Piazzi A et al. (1996) Successful induction of ovulation and completed pregnancy using r-LH and r-FSH in a woman with Kallmann’s syndrome. Hum Reprod 11: 70–1
Grumbach MM (2005) A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocr Metab 90: 3122–7. Epub 2005 Feb 22.
Fuexer F, Carlier R, Iffenecker C et al. (1996) Magnetic resonance imaging of the olfactory pathways in Kallmann de Morsier syndrome. J Neuroradiol, 1996; 23: 223–30
Quinton R, Duke VM, De Zoysa PA et al. (1996) The neuroradiology of Kallmann’s syndrome: a genotypic and phenotypic analysis. J Clin Endocr Metab 81:3010–7
Hardelin JP, Levilliers J, Young J et al. (1993) Xp 22.3 deletions in isolated familial Kallmann’s syndrome. J Clin Endocr Metab 76, 827–37
Hardelin JP (2001) Kallmann syndrome: towards molecular pathogenesis. Mol Cell Endocrinol 179: 75–81
Dode C, Hardelin JP (2004) Kallmann syndrome: fibroblast growth factor signaling insufficiency? J Mol Med 82: 725–34. Epub 2004 Sep 8
Hermanussen M, Sippell WG (1985) Heterogeneity of Kallmann’s syndrome. Clin Genet 28: 106–11
Massin N, Pêcheux C, Eloit C et al. (2003) X-Chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. J Clin Endocr Metab 88: 2003–8
Hipkin LJ, Casson IF, Davis JC (1990) Identical twins discordant for Kallmann’s syndrome. J Med Genet 27: 198–9
Legouis R, Hardelin JP, Levilliers J et al. (1991) The candidate gene for the X-linked Kallmann’s syndrome encodes a protein related to adhesion molecules. Cell 87: 423–35
Albuisson J, Pêcheux C, Carel JC et al. (2005) Kallmann Syndrome: 14 novel mutations in KAL1 and FGFR1 (Kal2). Hum Mut 25: 98–109
Georgopoulos N, Pralong FP, Seidman JG et al. (1997) Low incidence of Kal-1 mutations in sporadic cases of gonadotropin releasing hormone (GnRH) deficiency: evidence for the existence of autosomal genes involved in GnRH expression. J Clin Endocr Metab 82: 213–7
Dode C, Levilliers J, Dupont JM et al. (2003) Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33: 463–5
Sato N, Katsumata N, Kagami M et al. (2004) Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocr Metab 89: 1079–88
Sato N, Hasegawa T, Hori N et al. (2005) Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1: report of three families: Case report. Hum Reprod [Epub ahead of print]
De Roux N, Young J, Misrahi M et al. (1997) A family with hypogonadotropic hypogonadism and mutations in the GnRH receptor. N Engl J Med 337: 1597–602
Layman LC, Cohen DP, Jim M et al. (1998) Mutations in GnRH receptor gene cause hypogonadotropic hypogonadism. Nat Genet 18: 14–5
De Roux N, Young J, Brailly-Tabard S et al. (1999) The same molecular defect of the gonadotropin releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J Clin Endocr Metab 84: 3450–4
de Roux N, Genin E, Carle JC et al. (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100: 10972–6. Epub 2003 Aug 27
Seminara SB, Messager S, Chatzidaki EE et al. (2003) The GPR54 gene as a regulator of puberty. N Engl J Med 349: 1614–27
Rights and permissions
Copyright information
© 2007 Springer-Verlag France
About this chapter
Cite this chapter
Young, J. (2007). Hypogonadisme hypogonadotrophique congénital: procréation, grossesses et descendance. In: Pathologie hypophysaire et grossesse. Springer, Paris. https://doi.org/10.1007/978-2-287-35572-1_11
Download citation
DOI: https://doi.org/10.1007/978-2-287-35572-1_11
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-35571-4
Online ISBN: 978-2-287-35572-1